Is Bruker Stock a Good Investment?
Bruker Investment Advice | BRKR |
- Examine Bruker's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Bruker's leadership team and their track record. Good management can help Bruker navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Bruker's business and its evolving consumer preferences.
- Compare Bruker's performance and market position to its competitors. Analyze how Bruker is positioned in terms of product offerings, innovation, and market share.
- Check if Bruker pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Bruker's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Bruker stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Bruker is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Bruker Stock
Researching Bruker's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company shares are held by company insiders. The book value of Bruker was currently reported as 11.92. The company last dividend was issued on the 2nd of December 2024.
To determine if Bruker is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Bruker's research are outlined below:
Bruker generated a negative expected return over the last 90 days | |
Bruker is unlikely to experience financial distress in the next 2 years | |
Over 80.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from MacroaxisInsider: Acquisition by Frank Laukien of 69866 shares of Bruker at 49.82 subject to Rule 16b-3 |
Bruker Quarterly Accounts Payable |
|
Bruker uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Bruker. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bruker's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
8th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Bruker's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Bruker's investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2007-10-29 | 2007-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2003-08-06 | 2003-06-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2003-05-07 | 2003-03-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2003-02-20 | 2002-12-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2002-11-04 | 2002-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2002-02-21 | 2001-12-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2001-05-08 | 2001-03-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2015-08-05 | 2015-06-30 | 0.17 | 0.19 | 0.02 | 11 |
Know Bruker's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Bruker is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bruker backward and forwards among themselves. Bruker's institutional investor refers to the entity that pools money to purchase Bruker's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Brown Advisory Holdings Inc | 2024-09-30 | 1.8 M | Amvescap Plc. | 2024-06-30 | 1.8 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.5 M | Alyeska Investment Group, L.p. | 2024-09-30 | 1.5 M | Goldman Sachs Group Inc | 2024-06-30 | 1.5 M | Td Asset Management Inc | 2024-09-30 | 1.5 M | Marshall Wace Asset Management Ltd | 2024-06-30 | 1.4 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | Bank Of America Corp | 2024-06-30 | 1.4 M | Fmr Inc | 2024-09-30 | 14.3 M | T. Rowe Price Investment Management,inc. | 2024-09-30 | 13 M |
Bruker's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.79 B.Market Cap |
|
Bruker's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.13 | 0.13 | |
Return On Capital Employed | 0.14 | 0.09 | |
Return On Assets | 0.10 | 0.11 | |
Return On Equity | 0.31 | 0.33 |
Determining Bruker's profitability involves analyzing its financial statements and using various financial metrics to determine if Bruker is a good buy. For example, gross profit margin measures Bruker's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Bruker's profitability and make more informed investment decisions.
Bruker's Earnings Breakdown by Geography
Evaluate Bruker's management efficiency
Bruker has return on total asset (ROA) of 0.0483 % which means that it generated a profit of $0.0483 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1973 %, meaning that it created $0.1973 on every $100 dollars invested by stockholders. Bruker's management efficiency ratios could be used to measure how well Bruker manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bruker's Return On Tangible Assets are relatively stable compared to the past year. As of 11/30/2024, Return On Assets is likely to grow to 0.11, while Return On Capital Employed is likely to drop 0.09. At this time, Bruker's Return On Tangible Assets are relatively stable compared to the past year. As of 11/30/2024, Intangibles To Total Assets is likely to grow to 0.23, while Intangible Assets are likely to drop slightly above 196.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 9.65 | 10.14 | |
Tangible Book Value Per Share | 3.42 | 3.59 | |
Enterprise Value Over EBITDA | 19.45 | 20.42 | |
Price Book Value Ratio | 7.81 | 14.38 | |
Enterprise Value Multiple | 19.45 | 20.42 | |
Price Fair Value | 7.81 | 14.38 | |
Enterprise Value | 536.2 M | 565.4 M |
Understanding the management dynamics of Bruker allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Dividend Yield 0.0034 | Forward Dividend Yield 0.0034 | Forward Dividend Rate 0.2 | Beta 1.204 |
Basic technical analysis of Bruker Stock
As of the 30th of November, Bruker shows the Standard Deviation of 2.7, mean deviation of 2.03, and Risk Adjusted Performance of (0.03). Bruker technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bruker market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Bruker is priced correctly, providing market reflects its regular price of 57.95 per share. Given that Bruker has information ratio of (0.1), we suggest you to validate Bruker's prevailing market performance to make sure the company can sustain itself at a future point.Bruker's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bruker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bruker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bruker insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bruker's Outstanding Corporate Bonds
Bruker issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bruker uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bruker bonds can be classified according to their maturity, which is the date when Bruker has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Bruker's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Bruker's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | (0.03) | |||
Market Risk Adjusted Performance | (0.14) | |||
Mean Deviation | 2.03 | |||
Coefficient Of Variation | (2,186) | |||
Standard Deviation | 2.7 | |||
Variance | 7.29 | |||
Information Ratio | (0.1) | |||
Jensen Alpha | (0.25) | |||
Total Risk Alpha | (0.58) | |||
Treynor Ratio | (0.15) | |||
Maximum Drawdown | 12.99 | |||
Value At Risk | (3.68) | |||
Potential Upside | 4.74 | |||
Skewness | 1.12 | |||
Kurtosis | 2.85 |
Risk Adjusted Performance | (0.03) | |||
Market Risk Adjusted Performance | (0.14) | |||
Mean Deviation | 2.03 | |||
Coefficient Of Variation | (2,186) | |||
Standard Deviation | 2.7 | |||
Variance | 7.29 | |||
Information Ratio | (0.1) | |||
Jensen Alpha | (0.25) | |||
Total Risk Alpha | (0.58) | |||
Treynor Ratio | (0.15) | |||
Maximum Drawdown | 12.99 | |||
Value At Risk | (3.68) | |||
Potential Upside | 4.74 | |||
Skewness | 1.12 | |||
Kurtosis | 2.85 |
Consider Bruker's intraday indicators
Bruker intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bruker stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 11964.76 | |||
Daily Balance Of Power | (0.49) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 58.17 | |||
Day Typical Price | 58.09 | |||
Price Action Indicator | (0.43) | |||
Period Momentum Indicator | (0.43) | |||
Relative Strength Index | 40.45 |
Bruker Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 5th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 9th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Bruker Stock media impact
Far too much social signal, news, headlines, and media speculation about Bruker that are available to investors today. That information is available publicly through Bruker media outlets and privately through word of mouth or via Bruker internal channels. However, regardless of the origin, that massive amount of Bruker data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bruker news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bruker relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bruker's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bruker alpha.
Bruker Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bruker can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bruker Historical Investor Sentiment
Investor biases related to Bruker's public news can be used to forecast risks associated with an investment in Bruker. The trend in average sentiment can be used to explain how an investor holding Bruker can time the market purely based on public headlines and social activities around Bruker. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bruker's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bruker and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bruker news discussions. The higher the estimate score, the more favorable the investor's outlook on Bruker.
Bruker Corporate Executives
Elected by the shareholders, the Bruker's board of directors comprises two types of representatives: Bruker inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bruker. The board's role is to monitor Bruker's management team and ensure that shareholders' interests are well served. Bruker's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bruker's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gerald Herman | Interim CFO, Principal Accounting Officer | Profile | |
Gerald CPA | Executive CFO | Profile |
Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.